Amanda Lewis, PA
Surgical · Norman, OKNPI 1861639395
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations.
Across 83 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$240
- Xeris Pharmaceuticals, Inc.$203
- Tandem Diabetes Care, Inc.$148
- Bayer$145
- Lilly USA, LLC$131
- Chiesi USA, Inc.$83
- plus $683 from 20 others
What the payments were for
- Food & beverage$1,633100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 14 | $240 |
| Xeris Pharmaceuticals, Inc. | 10 | $203 |
| Tandem Diabetes Care, Inc. | 6 | $148 |
| Bayer | 9 | $145 |
| Lilly USA, LLC | 6 | $131 |
| Chiesi USA, Inc. | 4 | $83 |
| Medtronic | 4 | $81 |
| Hologic Sales And Service, LLC | 3 | $67 |
| Ascendis Pharma Endocrinology Inc | 3 | $58 |
| Amgen | 3 | $50 |
| BETA Bionics, Inc. | 3 | $47 |
| Insulet Corporation | 2 | $46 |
| Dexcom, Inc. | 2 | $44 |
| AbbVie | 2 | $41 |
| Cequr Corporation | 1 | $39 |
| Boehringer Ingelheim | 1 | $29 |
| Nevro Corp. | 1 | $24 |
| Mannkind Corporation | 1 | $23 |
| Baxter Healthcare | 1 | $22 |
| Novartis | 1 | $22 |
| Novo Nordisk | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Halozyme Inc | 1 | $16 |
| Innocoll Pharmaceuticals Limited | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Baudax Bio Inc. | 1 | $12 |
How this compares
$1,633 in reported general payments places this provider in the 75th percentile of 94 surgical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcitriol | 21 | $166 |
| Levothyroxine Sodium | 13 | $88 |
Paid to pharmacies, not to this prescriber.
Other surgical in Norman
- John GiraldoNorman$946
- Leigh LangleyNorman$539
- Lara GreenNorman$276
- Kayla HaleOklahoma City$36K
- Randall PapeOklahoma City$25K
- Anne EdmondsTulsa$15K
- Ian GordonOklahoma City$14K
- Isaac EdmondsTulsa$7K
- Camryn CorwinTulsa$5K
- Eduardo GarciaOklahoma City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.